Effect of functional bread rich in potassium, g-aminobutyric acid and angiotensin-converting enzyme inhibitors on blood pressure, glucose metabolism and endothelial function a double-blind randomized crossover clinical trial

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Effect of functional bread rich in potassium, g-aminobutyric acid and angiotensin-converting enzyme inhibitors on blood pressure, glucose metabolism and endothelial function a double-blind randomized crossover clinical trial. / Becerra-Tomas, Nerea; Guasch-Ferre, Marta; Quilez, Joan; Merino, Jordi; Ferre, Raimon; Diaz-López, Andres; Bulló, Monica; Hernández-Alonso, Pablo; Palau-Galindo, Antoni; Salas-Salvadó, Jordi.

In: Medicine, Vol. 94, No. 46, 2015, p. e1807.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Becerra-Tomas, N, Guasch-Ferre, M, Quilez, J, Merino, J, Ferre, R, Diaz-López, A, Bulló, M, Hernández-Alonso, P, Palau-Galindo, A & Salas-Salvadó, J 2015, 'Effect of functional bread rich in potassium, g-aminobutyric acid and angiotensin-converting enzyme inhibitors on blood pressure, glucose metabolism and endothelial function a double-blind randomized crossover clinical trial', Medicine, vol. 94, no. 46, pp. e1807. https://doi.org/10.1097/MD.0000000000001807

APA

Becerra-Tomas, N., Guasch-Ferre, M., Quilez, J., Merino, J., Ferre, R., Diaz-López, A., Bulló, M., Hernández-Alonso, P., Palau-Galindo, A., & Salas-Salvadó, J. (2015). Effect of functional bread rich in potassium, g-aminobutyric acid and angiotensin-converting enzyme inhibitors on blood pressure, glucose metabolism and endothelial function a double-blind randomized crossover clinical trial. Medicine, 94(46), e1807. https://doi.org/10.1097/MD.0000000000001807

Vancouver

Becerra-Tomas N, Guasch-Ferre M, Quilez J, Merino J, Ferre R, Diaz-López A et al. Effect of functional bread rich in potassium, g-aminobutyric acid and angiotensin-converting enzyme inhibitors on blood pressure, glucose metabolism and endothelial function a double-blind randomized crossover clinical trial. Medicine. 2015;94(46):e1807. https://doi.org/10.1097/MD.0000000000001807

Author

Becerra-Tomas, Nerea ; Guasch-Ferre, Marta ; Quilez, Joan ; Merino, Jordi ; Ferre, Raimon ; Diaz-López, Andres ; Bulló, Monica ; Hernández-Alonso, Pablo ; Palau-Galindo, Antoni ; Salas-Salvadó, Jordi. / Effect of functional bread rich in potassium, g-aminobutyric acid and angiotensin-converting enzyme inhibitors on blood pressure, glucose metabolism and endothelial function a double-blind randomized crossover clinical trial. In: Medicine. 2015 ; Vol. 94, No. 46. pp. e1807.

Bibtex

@article{4d0c47c167724f07b2cfbd343b896214,
title = "Effect of functional bread rich in potassium, g-aminobutyric acid and angiotensin-converting enzyme inhibitors on blood pressure, glucose metabolism and endothelial function a double-blind randomized crossover clinical trial",
abstract = "Because it has been suggested that food rich in g-aminobutyric acid (GABA) or angiotensin-converting enzyme inhibitor (ACEI) peptides have beneficial effects on blood pressure (BP) and other cardiovascular risk factors, we tested the effects of low-sodium bread, but rich in potassium, GABA, and ACEI peptides on 24-hour BP, glucose metabolism, and endothelial function. A randomized, double-blind, crossover trial was conducted in 30 patients with pre or mild-to-moderate hypertension, comparing three 4-week nutritional interventions separated by 2-week washout periods. Patients were randomly assigned to consume 120 g/day of 1 of the 3 types of bread for each nutritional intervention: conventional wheat bread (CB), low-sodium wheat bread enriched in potassium (LSB), and low-sodium wheat bread rich in potassium, GABA, and ACEI peptides (LSBAfter LSB Compared with the consumption of CB or LSB, no greater beneficial effects on 24-hour BP, endothelial function, or glucose metabolism were demonstrated after the consumption of LSBG in a population with pre or mild-to-moderate hypertension. Further studies are warranted to clarify the effect of GABA on BP, preferably using a specific design for noninferiority trials and ambulatory BP monitoring as a measure of BP.",
author = "Nerea Becerra-Tomas and Marta Guasch-Ferre and Joan Quilez and Jordi Merino and Raimon Ferre and Andres Diaz-L{\'o}pez and Monica Bull{\'o} and Pablo Hern{\'a}ndez-Alonso and Antoni Palau-Galindo and Jordi Salas-Salvad{\'o}",
note = "Publisher Copyright: {\textcopyright} 2015 Wolters Kluwer Health, Inc. All rights reserved.",
year = "2015",
doi = "10.1097/MD.0000000000001807",
language = "English",
volume = "94",
pages = "e1807",
journal = "Medicine (Baltimore)",
issn = "0025-7974",
publisher = "Wolters Kluwer Health, Inc.",
number = "46",

}

RIS

TY - JOUR

T1 - Effect of functional bread rich in potassium, g-aminobutyric acid and angiotensin-converting enzyme inhibitors on blood pressure, glucose metabolism and endothelial function a double-blind randomized crossover clinical trial

AU - Becerra-Tomas, Nerea

AU - Guasch-Ferre, Marta

AU - Quilez, Joan

AU - Merino, Jordi

AU - Ferre, Raimon

AU - Diaz-López, Andres

AU - Bulló, Monica

AU - Hernández-Alonso, Pablo

AU - Palau-Galindo, Antoni

AU - Salas-Salvadó, Jordi

N1 - Publisher Copyright: © 2015 Wolters Kluwer Health, Inc. All rights reserved.

PY - 2015

Y1 - 2015

N2 - Because it has been suggested that food rich in g-aminobutyric acid (GABA) or angiotensin-converting enzyme inhibitor (ACEI) peptides have beneficial effects on blood pressure (BP) and other cardiovascular risk factors, we tested the effects of low-sodium bread, but rich in potassium, GABA, and ACEI peptides on 24-hour BP, glucose metabolism, and endothelial function. A randomized, double-blind, crossover trial was conducted in 30 patients with pre or mild-to-moderate hypertension, comparing three 4-week nutritional interventions separated by 2-week washout periods. Patients were randomly assigned to consume 120 g/day of 1 of the 3 types of bread for each nutritional intervention: conventional wheat bread (CB), low-sodium wheat bread enriched in potassium (LSB), and low-sodium wheat bread rich in potassium, GABA, and ACEI peptides (LSBAfter LSB Compared with the consumption of CB or LSB, no greater beneficial effects on 24-hour BP, endothelial function, or glucose metabolism were demonstrated after the consumption of LSBG in a population with pre or mild-to-moderate hypertension. Further studies are warranted to clarify the effect of GABA on BP, preferably using a specific design for noninferiority trials and ambulatory BP monitoring as a measure of BP.

AB - Because it has been suggested that food rich in g-aminobutyric acid (GABA) or angiotensin-converting enzyme inhibitor (ACEI) peptides have beneficial effects on blood pressure (BP) and other cardiovascular risk factors, we tested the effects of low-sodium bread, but rich in potassium, GABA, and ACEI peptides on 24-hour BP, glucose metabolism, and endothelial function. A randomized, double-blind, crossover trial was conducted in 30 patients with pre or mild-to-moderate hypertension, comparing three 4-week nutritional interventions separated by 2-week washout periods. Patients were randomly assigned to consume 120 g/day of 1 of the 3 types of bread for each nutritional intervention: conventional wheat bread (CB), low-sodium wheat bread enriched in potassium (LSB), and low-sodium wheat bread rich in potassium, GABA, and ACEI peptides (LSBAfter LSB Compared with the consumption of CB or LSB, no greater beneficial effects on 24-hour BP, endothelial function, or glucose metabolism were demonstrated after the consumption of LSBG in a population with pre or mild-to-moderate hypertension. Further studies are warranted to clarify the effect of GABA on BP, preferably using a specific design for noninferiority trials and ambulatory BP monitoring as a measure of BP.

U2 - 10.1097/MD.0000000000001807

DO - 10.1097/MD.0000000000001807

M3 - Journal article

C2 - 26579797

AN - SCOPUS:84948659485

VL - 94

SP - e1807

JO - Medicine (Baltimore)

JF - Medicine (Baltimore)

SN - 0025-7974

IS - 46

ER -

ID: 358641523